| BHC-10 |
A |
09:00 AM - 09:10 AM |
OUTCOME OF LOW DOSE AZACITIDINE IN PATIENTS OF LOWER RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) |
KAUSTAV GHOSH |
| BHC-3 |
A |
09:10 AM - 09:20 AM |
TARGETING INTRACELLULAR CALCIUM: A NOVEL THERAPEUTIC STRATEGY FOR SICKLE CELL DISEASE |
PRASHANT WARANG |
| BHC-5 |
A |
09:20 AM - 09:30 AM |
STUDY OF BONE MINERAL DENSITY IN PATIENTS OF HEMOGLOBINOPATHIES. |
GANESH RAUT |
| BHC-9 |
A |
09:30 AM - 09:40 AM |
PLATELET INDICES AND NEUTROPHIL TO LYMPHOCYTE RATIO IN HYPERTENSIVE DISORDERS IN PREGNANCY: A CASE CONTROL STUDY |
MANODEEP BARAI |
| BHC-46 |
A |
09:40 AM - 09:50 AM |
A JOURNEY OF HB E ?ETA THALASSEMIA WITH THALIDOMIDE OVER TIME : THERAPEUTIC BENEFITS, SAFETY AND TOLERABILITY |
CHIRASREE SANYAL |
| BHC-11 |
A |
09:50 AM - 10:00 AM |
LARGE SCALE COMMUNITY-BASED SICKLE CELL SURVEILLANCE IN AN ABORIGINAL POPULATION FROM WESTERN INDIA |
UDAY YANAMANDRA |
| BHL-32 |
B |
09:00 AM - 09:10 AM |
THE SPURIOUSLY HIGH NEUTROPHIL CELL COUNTER POPULATION DATA IN APML- A CASE SERIES |
SNEHIL KUMAR |
| BHL-3 |
B |
09:10 AM - 09:20 AM |
AN OBSERVATIONAL STUDY ON THE VARIABILITY OF NUTRITIONAL STATUS AND ITS IMPACT ON OUTCOMES IN RECIPIENTS OF HAEMATOPOIETIC STEM CELL TRANSPLANT |
MANASI GUPTA |
| BHL-5 |
B |
09:20 AM - 09:30 AM |
REAL WORLD DATA ON THE USE OF EXTRACORPOREAL PHOTOPHERESIS FOR THE TREATMENT OF GRAFT VERSUS HOST DISEASE |
YASH PATEL |
| BHL-7 |
B |
09:30 AM - 09:40 AM |
THE ROLE OF CYTOGENETIC ABERRATIONS ON RISK ASSESSMENT AND PROGNOSIS IN MYELODYSPLASTIC SYNDROMES |
BIBHAS KAR |
| BHL-8 |
B |
09:40 AM - 09:50 AM |
HAEMATOPOIETIC STEM CELL TRANSPLANTATION IN INHERITED BONE MARROW FAILURE SYNDROMES: A TERTIARY CARE CENTER EXPERIENCE |
ABINAYA D |
| BHL-9 |
B |
09:50 AM - 10:00 AM |
DESIGN, FABRICATION, AND CHARACTERIZATION OF A PAPER-BASED MICROFLUIDIC DEVICE FOR SERUM MULTI-NUTRIENT ASSAY BY COLORIMETRY |
KALPITA NATH |
| MHC-3 |
C |
09:00 AM - 09:10 AM |
MGUS PREVALENCE IN SPECIAL POPULATIONS:INSIGHTS FROM A LARGE-SCALE COMMUNITY STUDY FROM RURAL INDIA |
UDAY YANAMANDRA |
| MHC-4 |
C |
09:10 AM - 09:20 AM |
DIFFERENCES IN PERCEPTION OF SYMPTOM BURDEN AND TREATMENT GOALS REGARDING MYELOFIBROSIS IN INDIA: INLAND SURVEY INSIGHTS |
PRANTAR CHAKRABARTI |
| MHC-7 |
C |
09:20 AM - 09:30 AM |
AZACITIDINE AND VENETOCLAX COMBINATION AS FIRST LINE THERAPY IN ACUTE MYELOID LEUKAEMIA - A TERTIARY CARE CENTRE EXPERIENCE |
NAVEEN VAIRAMOORTHY |
| MHC-8 |
C |
09:30 AM - 09:40 AM |
CHILDHOOD LANGERHANS CELL HISTIOCYTOSIS (LCH) : EXPERIENCE FROM A TERTIARY CARE HOSPITAL IN EASTERN INDIA |
KAUSTAV GHOSH |
| MHC-11 |
C |
09:40 AM - 09:50 AM |
REAL WORLD OUTCOMES WITH THE USE OF INOTUZUMAB OZOGAMICIN IN RELAPSED/REFRACTORY B CELL ACUTE LYMPHOBLASTIC LEUKEMIA |
ARCHITA R |
| MHC-25 |
C |
09:50 AM - 10:00 AM |
CLINICAL PROFILE AND OUTCOMES OF YOUNG ADULTS WITH MULTIPLE MYELOMA: A DECADE EXPERIENCE |
ABINASH HOTA |
| MHL-1 |
D |
09:00 AM - 09:10 AM |
IMPACT OF CYTOGENETIC ABNORMALITIES ON CLINICO-GENETIC PROFILING FOR ENHANCED DIAGNOSIS AND PROGNOSIS IN MULTIPLE MYELOMA |
BIBHAS KAR |
| MHL-2 |
D |
09:10 AM - 09:20 AM |
DISTINGUISHING CHRONIC LYMPHOCYTIC LEUKEMIA FROM OTHER LYMPHOMAS: THE IMPORTANCE OF CD200, CD38 AND FMC7 EXPRESSION |
PRATISHTHA KATIYAR |
| MHL-3 |
D |
09:20 AM - 09:30 AM |
BEYOND BLOOD: FLOW CYTOMETRY APPLICATION IN HEMATOLOGICAL MALIGNANCIES VIA BODY FLUID ANALYSIS. |
ANGELICA BENNY |
| MHL-4 |
D |
09:30 AM - 09:40 AM |
HEMATRACK: NEXT GENERATION SEQUENCING ASSAY FOR HIGH SENSITIVITY MEASURABLE RESIDUAL DISEASE (MRD) MONITORING IN ACUTE LYMPHOBLASTIC LEUKEMIA |
GEOFFREY A. BEHRENS |
| MHL-5 |
D |
09:40 AM - 09:50 AM |
CYTOGENETIC PROFILE OF PATIENTS WITH MULTIPLE MYELOMA |
SHAGUN SEHGAL |
| MHL-6 |
D |
09:50 AM - 10:00 AM |
MATURE B-CELL LYMPHOPROLIFERATIVE DISORDERS GAMUT ON FLOW CYTOMETRIC IMMUNOPHENOTYPING AT A TERTIARY HEALTH CARE CENTRE IN THE BASE OF HIMALAYAS |
ROSHNI SAXENA |
| MHC-1 |
E |
09:00 AM - 09:08 AM |
THYROID PROFILE AND MOLECULAR RESPONSE IN PATIENTS OF CHRONIC MYELOID LEUKEMIA (CML) ON TYROSINE KINASE INHIBITOR (TKI) |
DHARANKUMAR P |
| MHC-5 |
E |
09:08 AM - 09:16 AM |
STUDY OF QUALITY OF LIFE ASSESSMENT IN CHRONIC MYELOID LEUKEMIA RECEIVING LONG TERM THERAPY WITH TYROSINE KINASE INHIBITORS FROM A TERTIARYCARE HOSPITAL |
ABINAYA D |
| MHC-6 |
E |
09:16 AM - 09:24 AM |
BEYOND NEPHROTIC SYNDROME: A DIAGNOSTIC JOURNEY OF AL AMYLOIDOSIS WITH PLASMA CELL DYSCRASIA |
SATYAKI MANDAL |
| MHC-9 |
E |
09:24 AM - 09:32 AM |
REAL-WORLD EXPERIENCE WITH GENERIC VENETOCLAX PLUS HYPOMETHYLATING AGENT INDUCTION THERAPY IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS IN RESOURCE-LIMITED SETTING: A SINGLE-CENTER STUDY FROM AIIMS |
ARJUN ARJUN |
| MHC-15 |
E |
09:32 AM - 09:40 AM |
LYMPHOMA SUBTYPE DISTRIBUTION, CLINICAL PRESENTATION AND OUTCOMES: OVER THE LAST DECADE FROM AN EASTERN INDIA CANCER CENTER |
PAYAL MANDAL |
| MHC-19 |
E |
09:40 AM - 09:48 AM |
OUTCOMES OF AZACITIDINE-VENETOCLAX THERAPY IN THE FRONT LINE SETTING IN ACUTE MYELOID LEUKEMIA |
SAIKIRAN V |
| MHC-20 |
E |
09:48 AM - 09:56 AM |
CLINICAL OUTCOMES OF PH+ ALL IN PEDIATRIC AGE GROUP: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTER IN EASTERN INDIA |
CHINMAYA MAHAPATRA |
| MHC-26 |
E |
09:56 AM - 10:04 AM |
PANHYPOPITUITARISM AND OSTEOLYTIC LESIONS: A RARE PRESENTATION OF B-LYMPHOBLASTIC LYMPHOMA |
JEMIMA EVANGELYN T |
| MHC-27 |
E |
10:04 AM - 10:12 AM |
RESPONSE ASSESSMENT OF GENERIC TYROSINE KINASE INHIBITORS IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA- CHRONIC PHASE PATIENTS- A PROSPECTIVE STUDY IN A TERTIARY CARE CENTRE IN NORTH EAST INDIA |
ANANYA CHOUDHURI |
| MHC-28 |
E |
06:30 PM - 06:38 PM |
UNUSUAL PRESENTATION OF DUFFUSE LARGE B CELL LYMPHOMA |
ANSHIKA SINHA |
| MHC-31 |
E |
06:38 PM - 06:46 PM |
ASSESSMENT OF EARLY OUTCOME AND OPTIMISING INFRASTRUCTURAL UTILISATION OF THE DYNAMIC RISK-STRATIFICATION BASED ICICLE-PROTOCOL FOR MANAGEMENT OF CHILDHOOD ALL IN RESOURCE POOR TERTIARY CARE CENTRE |
STUTI ROY |
| MHC-35 |
E |
06:46 PM - 06:54 PM |
ELEVATED PLATELET COUNTS:TRIPLE NEGATIVE ESSENTIAL THROMBOCYTOSIS HIDING AS REACTIVE THROMBOCYTOSIS |
AKARSH DIXIT |
| MHC-37 |
E |
06:54 PM - 07:02 PM |
ACUTE PROMYELOCYTIC LEUKEMIA : CLINIC-PATHOLOGICAL ANALYSIS AND SHORT TERM TREATMENT OUTCOME IN A TERTIARY CARE HOSPITAL IN EASTERN INDIA |
SUBHRA KAMAL SAHA |
| MHC-38 |
E |
07:02 PM - 07:10 PM |
PEDIATRIC PRECURSOR B -CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH BULKY MEDIASTINAL MASS WITH MALIGNANT PLEURAL AND PERICARDIAL EFFUSION WITH SUPERIOR VENA CAVA OBSTRUCTION SYNDROME WITH KRAS |
PRISLA DALTON |
| MHC-41 |
E |
07:10 PM - 07:18 PM |
HEMATOPOIETIC STEM CELL TRANSPLANT OUTCOMES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA : A SINGLE CENTER STUDY |
GRISHMA SUKHWAL |
| MHC-42 |
E |
07:18 PM - 07:26 PM |
CLINICAL OUTCOMES OF MULTIPLE MYELOMA POST AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANT: A SINGLE CENTRE STUDY |
NEHA MOHANLAL MOTWANI |
| MHC-44 |
E |
07:26 PM - 07:34 PM |
CLINICOEPIDEMIOLOGICAL STUDY OF NEWLY DIAGNOSED MULTIPLE MYELOMA WITH SPECIAL REFERENCE TO PROGNOSIS |
NEERAJ DHAMEJA |
| MHC-45 |
E |
07:34 PM - 07:42 PM |
REAL WORLD OUTCOMES OF AZA/VEN INDUCTION FOLLOWED BY INTERMEDIATE DOSE CYTARABINE BASED CONSOLIDATION THERAPY AML |
SHAIKH MOHD RIZWAN |
| MHC-46 |
E |
07:42 PM - 07:50 PM |
OUTCOME OF HIGH DOSE IMATINIB VERSUS IMATINIB PLUS DECITABINE IN PATIENTS WITH ACCELERATED PHASE OR IMATINIB RESISTANT CASES OF CHRONIC MYELOID LEUKEMIA |
PRIYANKA ASAWA |
